X4 Pharmaceuticals, Inc

Ownership Transactions Reported by 21 Insiders

Symbol
XFOR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
61 North Beacon Street, 4 Th Floor, Boston, MA

Insiders trading volume in the past year

X4 Pharmaceuticals, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paula Ragan President and CEO, Director $1.52M -$197K -11.5% Feb 12, 2025
Adam R. Craig Executive Chairman, Director $1.14M Aug 12, 2025
John Volpone President $1.14M Aug 12, 2025
David Kirske Chief Financial Officer $758K Aug 12, 2025
Mary DiBiase Chief Operating Officer $518K -$48.4K -8.55% Feb 12, 2025
Christophe Arbet-Engels Chief Medical Officer $392K -$5.28K -1.33% Feb 12, 2025
Adam S. Mostafa Chief Financial Officer $386K -$161K -29.4% Feb 12, 2025
Arthur Taveras Chief Scientific Officer $218K -$43.3K -16.5% Oct 4, 2024
Derek Meisner Chief Legal Officer $131K Aug 17, 2022
Diego Cadavid Chief Medical Officer $93.7K Mar 1, 2022
William Aliski Director $85.2K Jun 10, 2024
Alison Frances Lawton Director $85.2K Jun 10, 2024
Mark Baldry Chief Commercial Officer $62.9K -$15.1K -19.4% May 16, 2025
Rene Russo Director $7.68K Jun 2, 2021
Natasha Fay Thoren Chief Legal Officer $1.8K May 20, 2025
Murray Stewart Director $1.5K Jun 9, 2025
Keith Woods Director $1.14K Jun 9, 2025
Michael S. Wyzga Director $1.06K Jun 9, 2025
Francoise de Craecker Director $897 Jun 9, 2025
D. W. J. Mcgirr Director $897 Jun 9, 2025
Gary Bridger Director $897 Jun 9, 2025

Recent Insider Transactions by Companies or Individuals for X4 Pharmaceuticals, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.